Valproic acid Withdrawn Phase 2 Trials for Bipolar Disorder (BD) / Depression, Bipolar Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02625779Combined Cytidine and Creatine-containing Drug in the Treatment of the Bipolar Depression
NCT01543139Cytidine- and Creatine-Containing Drug in Treating Bipolar Depression